RxDoctor Payments Data

Michael Williams, MD

Family Medicine · Newton, KSNPI 1043229149

Payments from drug & device makers

$566in general payments, 2019–2025

Across 43 payments — averaging $13.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$152
  • Amgen$79
  • Boehringer Ingelheim$46
  • Novo Nordisk$44
  • Astellas Pharma US Inc$43
  • Alkermes, Inc.$28
  • plus $174 from 11 others

What the payments were for

  • Food & beverage$55298%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$566 in reported general payments places this provider in the 50th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$29,080
Medicare patients
349
Services billed
3,296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin164$184,129
XareltoRivaroxaban89$104,019
TrulicityDulaglutide77$97,057
OzempicSemaglutide90$94,085
EliquisApixaban113$85,635
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$41,786
JanuviaSitagliptin Phosphate42$37,142
Tresiba Flextouch U-100Insulin Degludec37$28,113
MyrbetriqMirabegron54$12,288
RytaryCarbidopa/Levodopa21$12,229
ShingrixVaricella-Zoster Ge/As01b/Pf47$10,214
Janumet XrSitagliptin Phos/Metformin Hcl16$9,568
Formoterol Fumarate21$9,514
Breo ElliptaFluticasone/Vilanterol20$8,997
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen391$8,904

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$46$190,428176 claims
Johnson & JohnsonXarelto$13$104,01989 claims
Lilly USA, LLCTrulicity$16$97,05777 claims
Novo NordiskOzempic$44$94,08590 claims
PfizerEliquis, Abrysvo$152$92,910136 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta$12$60,997123 claims
MerckJanuvia, Janumet Xr$11$46,71058 claims
Astellas Pharma US IncMyrbetriq$43$12,28854 claims
Sanofi-aventis U.S. LLCLantus$27$3,92112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Newton

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →